View ValuationCryomass Technologies 将来の成長Future 基準チェック /06現在、 Cryomass Technologiesの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Machinery 収益成長16.8%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Apr 02Cryomass Technologies Inc. announced delayed annual 10-K filingOn 04/01/2025, Cryomass Technologies Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Apr 02Cryomass Technologies Inc. announced delayed annual 10-K filingOn 04/01/2024, Cryomass Technologies Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Nov 15Cryomass Technologies Inc. announced delayed 10-Q filingOn 11/14/2023, Cryomass Technologies Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jul 08CryoMass Technologies Inc. Provides Update on Commercial Processing PhaseCryoMass Technologies Inc. announced the successful transition from beta testing to commercial-level processing of its Trichome Separation Beta unit, also known as "CryoSift Separator". Since acquiring all intellectual property from CryoCann USA Corp, CryoMass has achieved remarkable strides in advancing and protecting its proprietary technology. Prior to the CryoCann asset acquisition, the technology had undergone six years of intensive research and development, but it had not been validated at an industrial scale. CryoMass has now achieved a major milestone by successfully designing and constructing an industrial-scale Beta system, which has undergone rigorous testing across multiple phases. This comprehensive journey, starting from the initial industrial design to the completion and testing of the first prototype, hasaid a solid foundation for CryoMass to embark on commercial-level processing. This achievement marks a significant leap forward for the Company. Following the completion of the CryoSift Separator Beta unit's build, CryoMass initially installed the unit at RedTape Core Partners LLC's licensed Coastal Refinement Solutions ("Coastal"), California, processing center in mid-December, pursuant to a multi-state licensing agreement that previously announced CryoMass, in collaboration with Coastal's extraction team, conducted trial runs on the Beta unit and identified areas for optimization to enhance performance. After completing the necessary modifications, a second series of biomass test runs began. During the second series of runs, the company focussed on evaluating the system's reliability, performance, and safety, established optimal cleaning and maintenance procedures, and determined the final design for the first serialized CryoSift Separator build. The company also captured efficiency data and started to establish Standard Operating Procedures (SOPs) for processing CryoSift (trichomes separated using the Company‘s proprietary method) in either a hydrocarbon-based extraction system or for producing solventless extracts. Throughout this phase, the CryoMass team closely monitored stress points, and performed necessary maintenance and adjustments during periods of downtime.お知らせ • Dec 08Cryomass Technologies Inc., Annual General Meeting, Jun 12, 2023Cryomass Technologies Inc., Annual General Meeting, Jun 12, 2023, at 10:00 Mountain Daylight.お知らせ • Aug 10CryoMass Technologies Inc. Appoints Mike Stringile to Lead Global SalesCryoMass Technologies Inc. appointed Mike Stringile to lead its worldwide sales team as it prepares to launch its first commercial installation next month in Monterey, California. Mr. Stringile brings unsurpassed cannabis industry extraction knowledge and sales experience to CryoMass. Mike began his extraction career working in the oil and gas industry in Fort McMurray, Alberta, where he was immersed in the complex world of extracting hydrocarbons from oil sands. After spending more than seven years honing his technical knowledge of hydrocarbon extraction processes, Mike was given the opportunity to apply his extraction expertise to the burgeoning new cannabis industry. In November 2018, Mr. Stringile joined an upstart C02 extraction company based in Kelowna, British Columbia, called Vitalis Extraction Technologies. It didn't take long for Mike's expertise to pay off. Mike integrated his oil and gas industry knowledge into the design of their extractors, which resulted in the development of C02 extractors for the cannabis industry. Simultaneously Mike built an ancillary sales department that did much more than sell extractors; it sold much-needed extraction knowledge and process integration expertise to cannabis companies. In the first 18 months, Mike's sales division generated more than $18 million in revenues for Vitalis. Then in March 2020, during the Covid lockdowns, Mr. Stringile co-founded AGMS Solutions Inc., which continues to provide a comprehensive suite of extraction-oriented consulting services to the cannabis industry. AGMS quickly developed a worldwide network of cannabis cultivators, extractors, and finished goods producers seeking to avail themselves of advanced and customized extraction solutions.お知らせ • Aug 06Cryomass Technologies Inc. Prepares for the Market Launch of Its Revolutionary Trichome SeparatorCryoMass Technologies Inc. announced that rigorous testing of its patented cryogenic trichrome separation system has yielded results in all key areas of interest that either met or significantly surpassed pre-testing expectations. The Company is now busily preparing to deliver its first commercial unit to an operating partner based in the heart of the largest cannabis production region of the larger cannabis market, California. This Monterey-based company manufactures premium extracts for their own brand and several of the more prominent, better-known brands in California. Their extensive expertise in producing high-quality, standardized extracts should prove invaluable as company refine standard operating procedures (SOP) to guide product development for future customers. Together company are establishing a toll processing station at their sophisticated Monterey facility, where company expect to process cannabis on behalf of some of California's leading cannabis cultivators, many of which are already close business relationships. The Company is confident this partnership will begin generating revenues in the 4th quarter of 2022 and anticipate a steep ramp-up in revenues throughout 2023. The CryoMass system enables cannabis and hemp cultivators and processors to optimize and streamline their processes, thus dramatically reducing costs while simultaneously capturing approximately 97% of the active elements and increasing the purity and quality of the products sold to consumers. Testing Phase Highlights; When comparing the results of the patented CryoMass system to traditional trichome separation systems, there is no comparison. Based on the processing of 25,000 lbs. of biomass, here are the results of trichome separation system versus nine leading traditional systems that do not and cannot utilize patented cryogenic, solventless separation process: It is important to note that one of the key reasons the CryoMass system is so much more efficient from a process and cost-saving perspective is that it is, to the best of knowledge, the only continuous-feed separation system while all others are batch-feed systems. Although the Company's initial focus is on the cannabis and hemp sector, there is tremendous potential to generate important revenue streams from processing other high-value, trichrome-rich plants where similar cost savings and end-product improvements can be realized.お知らせ • May 03Cryomass Technologies Inc., Annual General Meeting, Jun 20, 2022Cryomass Technologies Inc., Annual General Meeting, Jun 20, 2022, at 10:00 Mountain Daylight. Location: 1001 Bannock Street, Suite 612 Denver Colorado United States Agenda: To elect five directors to serve until the next annual meeting of stockholders and until their respective successors are duly elected and qualified; to ratify the appointment of BF Borgers, CPA PC as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022; to grant the Board of Directors the discretionary authority to amend the company’s articles of incorporation to effect a reverse stock split of the company’s common stock; and to consider other matters.お知らせ • Aug 17Andina Gold Corp. announced delayed 10-Q filingOn 08/16/2021, Andina Gold Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Mar 06+ 1 more updateAndina Gold Corp. (OTCPK:AGOL) entered into a non binding letter of agreement to acquire all assets of CryoCann USA Corporation from CryoCann USA Corporation for $6.9 million.Andina Gold Corp. (OTCPK:AGOL) entered into a non binding letter of agreement to acquire All Assets of CryoCann USA Corporation from CryoCann USA Corporation for $6.9 million on February 25, 2021. The Transaction consideration consists of $4,500,000 in cash at Closing to be paid by the Company to CryoCann and to be distributed among CryoCann shareholders as such shareholders will agree among themselves; $2,000,000 in initial working capital to be made available by the Company on a rolling/as needed basis to the Company division that will manage the Assets; 12,000,000 restricted shares of common stock of the Company to be provided to CryoCann shareholders to be distributed among CryoCann shareholders as such shareholders will agree among themselves and the execution of the employment and earn-out agreement. The proposed transaction remains subject to completion of a due diligence review by the Company, the Company’s Board of Directors approval of the Proposed Transaction, the Company’s ability to secure financing for the Proposed Transaction and the negotiation and execution of definitive agreements. Upon closing of the Proposed Transaction and as a condition precedent to closing, two employees and shareholders of CryoCann will enter into employment and earn-out agreements for a minimum of three years.お知らせ • Jan 22American Cannabis Company, Inc. (OTCPK:AMMJ) entered into a non-binding letter of intent to acquire Good Meds and BOSM Labs Operating Division Assets from Andina Gold Corp. (OTCPK:AGOL).American Cannabis Company, Inc. (OTCPK:AMMJ) entered into a non-binding letter of intent to acquire Good Meds and BOSM Labs Operating Division Assets from Andina Gold Corp. (OTCPK:AGOL) on January 21, 2021. Assets includes one cultivation operation and one hydrocarbon extraction laboratory and production center. The transaction is expected to close in second quarter of 2021.お知らせ • Oct 31Andina Gold Corp. Announces Board AppointmentsAndina Gold Corp. announced further development of the company's focus and strategy. At its meeting on October 29, 2020, the Company's Board of Directors reaffirmed its August 11 decision to shift away from the U.S. cannabis market and toward exploration opportunities in previously inaccessible districts of Colombia's historically productive gold mining regions. At the August 11 meeting, as a step toward acting on its decision, the company added two Directors to its Board, Mr. Carlos Andrés Hernández and Mr. Gary Artmont, who brought extensive experience in Colombian mining and mineral exploration. The new directors broadened the Company's capabilities, which already included expertise in finance, capital market and international governmental and regulatory matters. Andina Gold's Colombian subsidiary, Andina Gold Colombia S.A.S., was duly established in August 2020 and now is qualified to conduct business in the country.お知らせ • Jul 22Redwood Green Corp. Elects Christopher A. Hansen as Chief Executive OfficerEffective as of July 20, 2020, the Redwood Green Corp. elected Christopher A. Hansen as Chief Executive Officer. Mr. Hansen will not serve on the Company's Board of Directors. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Cryomass Technologies は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測OTCPK:CRYM - アナリストの将来予測と過去の財務データ ( )USD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数9/30/20240-9-1-1N/A6/30/20240-9-2-2N/A3/31/20240-14-3-2N/A12/31/20230-13-4-4N/A9/30/2023N/A-15-4-4N/A6/30/2023N/A-15-4-4N/A3/31/2023N/A-10-5-4N/A12/31/2022N/A-10-5-5N/A9/30/2022N/A-8-7-6N/A6/30/2022N/A-10-7-7N/A3/31/2022N/A-11-8-7N/A12/31/2021N/A-10-7-6N/A9/30/2021N/A-8-5-4N/A6/30/2021N/A-7-4-3N/A3/31/20211-5-3-3N/A12/31/20201-7-4-4N/A9/30/20201-7-4-4N/A6/30/20201-7-4-4N/A3/31/20200-7-3-3N/A12/31/20190-3-2-2N/A9/30/2019N/A-2-1-1N/A6/30/2019N/A-1-10N/A3/31/2019N/A0-10N/A12/31/2018N/A0-10N/A9/30/2018N/A000N/A6/30/2018N/A0N/A0N/A3/31/2018N/A0N/A0N/A12/31/2017N/A0N/A0N/A9/30/2017N/A0N/A0N/A6/30/2017N/A0N/A0N/A3/31/2017N/A0N/A0N/A12/31/2016N/A0N/A0N/A9/30/2016N/A0N/A0N/A6/30/2016N/A0N/A0N/A3/31/2016N/A0N/A0N/A12/31/2015N/A0N/A0N/A9/30/2015N/A0N/A0N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: CRYMの予測収益成長が 貯蓄率 ( 3.5% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: CRYMの収益がUS市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: CRYMの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: CRYMの収益がUS市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: CRYMの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: CRYMの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YCapital-goods 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/21 23:59終値2026/05/21 00:00収益2024/09/30年間収益2023/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Cryomass Technologies Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Apr 02Cryomass Technologies Inc. announced delayed annual 10-K filingOn 04/01/2025, Cryomass Technologies Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Apr 02Cryomass Technologies Inc. announced delayed annual 10-K filingOn 04/01/2024, Cryomass Technologies Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Nov 15Cryomass Technologies Inc. announced delayed 10-Q filingOn 11/14/2023, Cryomass Technologies Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jul 08CryoMass Technologies Inc. Provides Update on Commercial Processing PhaseCryoMass Technologies Inc. announced the successful transition from beta testing to commercial-level processing of its Trichome Separation Beta unit, also known as "CryoSift Separator". Since acquiring all intellectual property from CryoCann USA Corp, CryoMass has achieved remarkable strides in advancing and protecting its proprietary technology. Prior to the CryoCann asset acquisition, the technology had undergone six years of intensive research and development, but it had not been validated at an industrial scale. CryoMass has now achieved a major milestone by successfully designing and constructing an industrial-scale Beta system, which has undergone rigorous testing across multiple phases. This comprehensive journey, starting from the initial industrial design to the completion and testing of the first prototype, hasaid a solid foundation for CryoMass to embark on commercial-level processing. This achievement marks a significant leap forward for the Company. Following the completion of the CryoSift Separator Beta unit's build, CryoMass initially installed the unit at RedTape Core Partners LLC's licensed Coastal Refinement Solutions ("Coastal"), California, processing center in mid-December, pursuant to a multi-state licensing agreement that previously announced CryoMass, in collaboration with Coastal's extraction team, conducted trial runs on the Beta unit and identified areas for optimization to enhance performance. After completing the necessary modifications, a second series of biomass test runs began. During the second series of runs, the company focussed on evaluating the system's reliability, performance, and safety, established optimal cleaning and maintenance procedures, and determined the final design for the first serialized CryoSift Separator build. The company also captured efficiency data and started to establish Standard Operating Procedures (SOPs) for processing CryoSift (trichomes separated using the Company‘s proprietary method) in either a hydrocarbon-based extraction system or for producing solventless extracts. Throughout this phase, the CryoMass team closely monitored stress points, and performed necessary maintenance and adjustments during periods of downtime.
お知らせ • Dec 08Cryomass Technologies Inc., Annual General Meeting, Jun 12, 2023Cryomass Technologies Inc., Annual General Meeting, Jun 12, 2023, at 10:00 Mountain Daylight.
お知らせ • Aug 10CryoMass Technologies Inc. Appoints Mike Stringile to Lead Global SalesCryoMass Technologies Inc. appointed Mike Stringile to lead its worldwide sales team as it prepares to launch its first commercial installation next month in Monterey, California. Mr. Stringile brings unsurpassed cannabis industry extraction knowledge and sales experience to CryoMass. Mike began his extraction career working in the oil and gas industry in Fort McMurray, Alberta, where he was immersed in the complex world of extracting hydrocarbons from oil sands. After spending more than seven years honing his technical knowledge of hydrocarbon extraction processes, Mike was given the opportunity to apply his extraction expertise to the burgeoning new cannabis industry. In November 2018, Mr. Stringile joined an upstart C02 extraction company based in Kelowna, British Columbia, called Vitalis Extraction Technologies. It didn't take long for Mike's expertise to pay off. Mike integrated his oil and gas industry knowledge into the design of their extractors, which resulted in the development of C02 extractors for the cannabis industry. Simultaneously Mike built an ancillary sales department that did much more than sell extractors; it sold much-needed extraction knowledge and process integration expertise to cannabis companies. In the first 18 months, Mike's sales division generated more than $18 million in revenues for Vitalis. Then in March 2020, during the Covid lockdowns, Mr. Stringile co-founded AGMS Solutions Inc., which continues to provide a comprehensive suite of extraction-oriented consulting services to the cannabis industry. AGMS quickly developed a worldwide network of cannabis cultivators, extractors, and finished goods producers seeking to avail themselves of advanced and customized extraction solutions.
お知らせ • Aug 06Cryomass Technologies Inc. Prepares for the Market Launch of Its Revolutionary Trichome SeparatorCryoMass Technologies Inc. announced that rigorous testing of its patented cryogenic trichrome separation system has yielded results in all key areas of interest that either met or significantly surpassed pre-testing expectations. The Company is now busily preparing to deliver its first commercial unit to an operating partner based in the heart of the largest cannabis production region of the larger cannabis market, California. This Monterey-based company manufactures premium extracts for their own brand and several of the more prominent, better-known brands in California. Their extensive expertise in producing high-quality, standardized extracts should prove invaluable as company refine standard operating procedures (SOP) to guide product development for future customers. Together company are establishing a toll processing station at their sophisticated Monterey facility, where company expect to process cannabis on behalf of some of California's leading cannabis cultivators, many of which are already close business relationships. The Company is confident this partnership will begin generating revenues in the 4th quarter of 2022 and anticipate a steep ramp-up in revenues throughout 2023. The CryoMass system enables cannabis and hemp cultivators and processors to optimize and streamline their processes, thus dramatically reducing costs while simultaneously capturing approximately 97% of the active elements and increasing the purity and quality of the products sold to consumers. Testing Phase Highlights; When comparing the results of the patented CryoMass system to traditional trichome separation systems, there is no comparison. Based on the processing of 25,000 lbs. of biomass, here are the results of trichome separation system versus nine leading traditional systems that do not and cannot utilize patented cryogenic, solventless separation process: It is important to note that one of the key reasons the CryoMass system is so much more efficient from a process and cost-saving perspective is that it is, to the best of knowledge, the only continuous-feed separation system while all others are batch-feed systems. Although the Company's initial focus is on the cannabis and hemp sector, there is tremendous potential to generate important revenue streams from processing other high-value, trichrome-rich plants where similar cost savings and end-product improvements can be realized.
お知らせ • May 03Cryomass Technologies Inc., Annual General Meeting, Jun 20, 2022Cryomass Technologies Inc., Annual General Meeting, Jun 20, 2022, at 10:00 Mountain Daylight. Location: 1001 Bannock Street, Suite 612 Denver Colorado United States Agenda: To elect five directors to serve until the next annual meeting of stockholders and until their respective successors are duly elected and qualified; to ratify the appointment of BF Borgers, CPA PC as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022; to grant the Board of Directors the discretionary authority to amend the company’s articles of incorporation to effect a reverse stock split of the company’s common stock; and to consider other matters.
お知らせ • Aug 17Andina Gold Corp. announced delayed 10-Q filingOn 08/16/2021, Andina Gold Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Mar 06+ 1 more updateAndina Gold Corp. (OTCPK:AGOL) entered into a non binding letter of agreement to acquire all assets of CryoCann USA Corporation from CryoCann USA Corporation for $6.9 million.Andina Gold Corp. (OTCPK:AGOL) entered into a non binding letter of agreement to acquire All Assets of CryoCann USA Corporation from CryoCann USA Corporation for $6.9 million on February 25, 2021. The Transaction consideration consists of $4,500,000 in cash at Closing to be paid by the Company to CryoCann and to be distributed among CryoCann shareholders as such shareholders will agree among themselves; $2,000,000 in initial working capital to be made available by the Company on a rolling/as needed basis to the Company division that will manage the Assets; 12,000,000 restricted shares of common stock of the Company to be provided to CryoCann shareholders to be distributed among CryoCann shareholders as such shareholders will agree among themselves and the execution of the employment and earn-out agreement. The proposed transaction remains subject to completion of a due diligence review by the Company, the Company’s Board of Directors approval of the Proposed Transaction, the Company’s ability to secure financing for the Proposed Transaction and the negotiation and execution of definitive agreements. Upon closing of the Proposed Transaction and as a condition precedent to closing, two employees and shareholders of CryoCann will enter into employment and earn-out agreements for a minimum of three years.
お知らせ • Jan 22American Cannabis Company, Inc. (OTCPK:AMMJ) entered into a non-binding letter of intent to acquire Good Meds and BOSM Labs Operating Division Assets from Andina Gold Corp. (OTCPK:AGOL).American Cannabis Company, Inc. (OTCPK:AMMJ) entered into a non-binding letter of intent to acquire Good Meds and BOSM Labs Operating Division Assets from Andina Gold Corp. (OTCPK:AGOL) on January 21, 2021. Assets includes one cultivation operation and one hydrocarbon extraction laboratory and production center. The transaction is expected to close in second quarter of 2021.
お知らせ • Oct 31Andina Gold Corp. Announces Board AppointmentsAndina Gold Corp. announced further development of the company's focus and strategy. At its meeting on October 29, 2020, the Company's Board of Directors reaffirmed its August 11 decision to shift away from the U.S. cannabis market and toward exploration opportunities in previously inaccessible districts of Colombia's historically productive gold mining regions. At the August 11 meeting, as a step toward acting on its decision, the company added two Directors to its Board, Mr. Carlos Andrés Hernández and Mr. Gary Artmont, who brought extensive experience in Colombian mining and mineral exploration. The new directors broadened the Company's capabilities, which already included expertise in finance, capital market and international governmental and regulatory matters. Andina Gold's Colombian subsidiary, Andina Gold Colombia S.A.S., was duly established in August 2020 and now is qualified to conduct business in the country.
お知らせ • Jul 22Redwood Green Corp. Elects Christopher A. Hansen as Chief Executive OfficerEffective as of July 20, 2020, the Redwood Green Corp. elected Christopher A. Hansen as Chief Executive Officer. Mr. Hansen will not serve on the Company's Board of Directors.